Approval · Notice of Compliance 18867 · 2017
DEXIRON: Notice of Compliance 18867
Issued January 9, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18867
- Date
- January 9, 2017
- Company
- Luitpold Pharmaceuticals Inc.Shirley, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- An alternative stopper for the drug product packaging due to the lack of availability of the current stopper and 1ml vial is discontinued
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DEXIRON | Not yet assigned | — |
Medicinal ingredients
- IRON DEXTRAN COMPLEX 50 MG per ML